Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/09546634.2020.1799918 http://scihub22266oqcxt.onion/10.1080/09546634.2020.1799918 32691645!ä!32691645       J+Dermatolog+Treat 2022 ; 33 (2): 1111-1113 Nephropedia Template TP {{tp|p=32691645|t=2022. A case of severe psoriatic erythroderma with COVID-19 |pdf=|usr=}}{{32691645}} gab.com Text A case of severe psoriatic erythroderma with COVID-19 JO: J Dermatolog Treat http://www.kidney.de/pget.php?&tw=1&pmid=32691645 #FOAvip COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here, we report a 45-year-old homeless addicted male with second flare of psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was screened for SARS-CoV-2 before admission which all evaluations showed nagative results. The patient was treated and relatively controlled with cyclosporine and therefore he was discharged. During this interval, he not only discontinued his medication, but also became SARS-CoV-2 positive. It seems that both factors participated in flare of his erythroderma. Twit Text FOAVip A case of severe psoriatic erythroderma with COVID-19 ????J Dermatolog Treat http://www.kidney.de/pget.php?&tw=1&pmid=32691645 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32691645 #FOAvip English Wikipedia <ref>{{Cite pmid|32691645}}</ref> A case of severe psoriatic erythroderma with COVID-19 #MMPMID32691645 Ghalamkarpour F; Pourani MR; Abdollahimajd F; Zargari O J Dermatolog Treat 2022[Mar]; 33 (2): 1111-1113 PMID32691645show ga COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here, we report a 45-year-old homeless addicted male with second flare of psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was screened for SARS-CoV-2 before admission which all evaluations showed nagative results. The patient was treated and relatively controlled with cyclosporine and therefore he was discharged. During this interval, he not only discontinued his medication, but also became SARS-CoV-2 positive. It seems that both factors participated in flare of his erythroderma. |*COVID-19/complications[MESH] |*Dermatitis, Exfoliative/drug therapy/etiology[MESH] |Cyclosporine/therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH]A case of severe psoriatic erythroderma with COVID-19 (epmc).pdf DeepDyve Pubget Overpricing